07:31 AM EDT, 09/30/2025 (MT Newswires) -- Tilray Brands ( TLRY ) down 3.8% in the U.S. pre-market trading, said Tuesday it has expanded its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany.

The products, produced at Tilray's EU-GMP certified facility in Neumunster, reflect its commitment to provide physicians and pharmacies with EU-GMP certified medical cannabis options for patients.

"As a global leader in medical cannabis, supported by our advanced EU-GMP facility in Germany, Tilray continuously introduces new genetics bred to pharmaceutical standards at Neumunster. This approach enables us to provide reliable, patient-focused medical cannabis options," said Rajnish Ohri, managing director international at Tilray Brands ( TLRY ).

Tilray was last down at US$1.78 in New York trading. Its shares surged 60% to close at $2.57 on the Toronto Stock Exchange yesterday.